The first genotype-phenotype study on European carriers of CDH1 germline mutations

被引：0

作者：

Garcia-Pelaez, J. ^{[1
]}

Monteiro, R. ^{[1
]}

Sousa, L. ^{[1
]}

Pinheiro, H. ^{[1
]}

Castedo, S. ^{[1
,2
,3
]}

Garrido, L. ^{[2
]}

Teixeira, M. ^{[4
,5
]}

Michils, G. ^{[6
]}

Bours, V. ^{[5
,7
,8
]}

de Putter, R. ^{[5
,9
]}

Golmard, L.

Blanluet, M. ^{[10
]}

Colas, C. ^{[5
,10
]}

Benusiglio, P. ^{[11
]}

Aretz, S.

Spier, I. ^{[5
,12
,13
]}

Hueneburg, R. ^{[13
,14
]}

Gieldon, L. ^{[15
,16
]}

Schroeck, E. ^{[5
,15
,16
]}

Holinski-Feder, E.

Steinke, V. ^{[5
,17
,18
]}

Calistri, D.

Tedaldi, G. ^{[19
]}

Ranzani, G. ^{[20
]}

Genuardi, M. ^{[21
,22
]}

Silveira, C.

Silva, I. ^{[23
]}

Krajc, M.

Blatnik, A. ^{[5
,24
]}

Novakovic, S. ^{[24
]}

Patino-Garcia, A. ^{[25
,26
]}

Soto, J. ^{[27
]}

Lazaro, C. ^{[5
,28
]}

Capella, G. ^{[5
,28
]}

Brunet-Vidal, J. ^{[5
,29
]}

Balmana, J. ^{[5
,30
]}

Dominguez-Garrido, E. ^{[31
]}

Ligtenberg, M. ^{[5
,32
,33
]}

Fewings, E. ^{[34
,35
]}

Fitzgerald, R. ^{[36
]}

Woodward, E. ^{[5
,37
,38
]}

Evans, G. ^{[5
,39
]}

Hanson, H. ^{[40
]}

Lagerstedt-Robinson, K. ^{[41
,42
]}

Bajalica-Lagercrantz, S. ^{[5
,41
,42
]}

Egas, C. ^{[43
]}

Martinez-Bouzas, C. ^{[44
,45
]}

Dahan, K.

Feret, D. ^{[46
]}

Hoogerbrugge, N. ^{[5
,32
,33
]}

机构：

[1] IPATIMUP i3S, Porto, Portugal

[2] Ctr Hosp Univ Sao Joao CHSJ, Porto, Portugal

[3] Univ Porto, Fac Med, Porto, Portugal

[4] Inst Portugues Oncol Porto, IPO, Porto, Portugal

[5] European Reference Network Genet Tumour Risk Synd, Nijmegen, Netherlands

[6] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium

[7] Univ Liege, GIGA Inst, Lab Human Genet, Liege, Belgium

[8] Univ Hosp CHU, Ctr Genet, Liege, Belgium

[9] Univ Hosp Ghent, Dept Clin Genet, Ghent, Belgium

[10] Inst Curie, Dept Genet, Paris, France

[11] GH Pitie Salpetriere, Dept Genet, Paris, France

[12] Univ Bonn, Inst Human Genet, Bonn, Germany

[13] Univ Bonn, Natl Ctr Hereditary Tumor Syndromes, Bonn, Germany

[14] Univ Hosp Bonn, Dept Internal Med, Bonn, Germany

[15] Med Fak Carl Gustav Carus, Inst Klin Genet, Dresden, Germany

[16] German Canc Res Ctr DKFZ Heidelberg, German Canc Consortium DKTK, Natl Ctr Tumor Dis NCT Site Dresden, Core Unit Mol Tumordiagnost, Dresden, Germany

[17] Klinikum Univ Munchen, Med Klin & Poliklin 4, Campus Innenstadt, Munich, Germany

[18] MGZ Med Genet Zentrum, Munich, Germany

[19] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Biosci Lab, Meldola, Italy

[20] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Pavia, Italy

[21] Fdn Policlin Univ Gemelli IRCCS, UOC Genet Medica, Rome, Italy

[22] Univ Cattolica Sacro Cuore, Ist Med Genom, Rome, Italy

[23] Genomed Diagnost Med Mol SA, Lisbon, Portugal

[24] Inst Oncol Ljubljana, Dept Mol Diagnost, Ljubljana, Slovenia

[25] Univ Clin Navarra, Clin Genet Unit, Pamplona, Spain

[26] Univ Clin Navarra, CIMA LAB Diagnost, Pamplona, Spain

[27] Elche Univ Hosp, Mol Genet Lab, Elche, Spain

[28] CIBERONC, Catalan Inst Oncol, IDIBELL, Barcelona, Spain

[29] Catalan Inst Oncol, IDIBELL, IDIBGI, Barcelona Girona, Portugal

[30] Hosp Valle De Hebron, Barcelona, Spain

[31] Fdn Rioja Salud, Mol Diagnost Lab, Logrono, Spain

[32] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands

[33] Radboud Inst Mol Life Sci, Nijmegen, Netherlands

[34] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Acad Lab Med Genet, Cambridge, England

[35] Univ Cambridge, Cambridge, England

[36] Univ Cambridge, MRC, Canc Unit, Hutchison MRC, Cambridge, England

[37] Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, NW Genom Lab hub, Manchester, Lancs, England

[38] Univ Manchester, Sch Biol Sci, Div Evolut & Genom Sci, Acad Hlth Sci Ctr,Fac Sci, Manchester, Lancs, England

[39] Manchester Ctr Genom Med, Manchester, Lancs, England

[40] St Georges NHS Fdn Trust, London, England

[41] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden

[42] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden

[43] Biocant Biotechnol Innovat Ctr, Adv Serv Unit, Cantanhede, Portugal

[44] Biocruces Hlth Res Inst, Baracaldo, Spain

[45] Cruces Univ Hosp, Genet Serv, Mol Genet Lab, Baracaldo, Spain

[46] Inst Genet & Pathol, Gosselies, Belgium

[47] i3S, Porto, Portugal

[48] Ipatimup, Porto, Portugal

[49] FMUP, Porto, Portugal

[50] ERNGENTURIS, Porto, Portugal

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2020年 / 28卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

C10.3

引用

页码：61 / 63

页数：3

共 50 条

[21] Investigation of CDH1 germline mutations in Turkish patients with Kaposi's sarcoma
Celik, Betul
Tuncer, Seref Bugra
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2024, 49 (03): : 325 - 333
[22] Novel CDH1 germline mutations identified in Chinese gastric cancer patients
Chen, Qin-Hua
Deng, Wei
Li, Xiao-Wei
Liu, Xiu-Fang
Wang, Jing-Mei
Wang, Li-Feng
Xiao, Nong
He, Qiong
Wang, Ya-Ping
Fan, Yi-Mei
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (06) : 909 - 916
[23] High frequency of lobular breast cancer in CDH1 germline carriers supports update of clinical guidelines for CDH1 testing and pathological characterization
Garcia-Pelaez, J.
Dias, Alexandre
Guilford, Parry
Oliveira, Carla
EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1718 - 1719
[24] European Landscape of CDH1 germline mutations: a new tool to understand hereditary diffuse gastric cancer (HDGC)
Garcia Pelaez, J.
Monteiro, A.
Sousa, L.
Castedo, S.
Garrido, L.
Michils, G.
Bours, V.
de Putter, R.
Golmard, L.
Blanluet, M.
Colas, C.
Benusiglio, P.
Aretz, S.
Spier, I.
Hueneburg, R.
Gieldon, L.
Schroeck, E.
Holinski-Feder, E.
Steinke, V.
Calistri, D.
Tedaldi, G.
Nadia-Ranzani, G.
Genuardi, M.
Silveira, C.
Krajc, M.
Blatnik, A.
Novakovic, S.
Patino-Garcia, A.
Soto, J.
Lazaro, C.
Capella, G.
Brunet-Vidal, J.
Balmana, J.
Dominguez-Garrido, E.
Ligtenberg, M.
Fewings, E.
Fitzgerald, R.
Woodward, E.
Evans, G.
Hanson, H.
Lagerstedt-Robinson, K.
Bajalica-Lagercrantz, S.
Teixeira, M.
Hoogerbrugge, N.
Tischkowitz, M.
Oliveira, C.
EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1126 - 1128
[25] Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?
Corso, Giovanni
Sacchini, Virgilio
Pravettoni, Gabriella
Veronesi, Paolo
Bonanni, Bernardo
EJSO, 2019, 45 (10): : 1760 - 1761
[26] CDH1 (CADHERIN-1) GERMLINE MUTATIONS IN CHINESE DIFFUSE GASTRIC CANCER
Jia, Shuqin
Fan, Zhenhua
Bu, Zhaode
Li, Ziyu
Li, Ziran
Feng, Mengmeng
Hu, Ying
Zhang, Juan
Xie, Yuntao
Ji, Jiafu
ANTICANCER RESEARCH, 2015, 35 (07) : 4288 - 4289
[27] Hereditary gastric cancer caused by germline CDH1 gene mutations in the Netherlands
Kluijt, I.
Siemerink, E.
Ausems, M.
Ligtenberg, M.
de Jong, D.
Sijmons, R.
Plukker, J. T.
van Hillegersberg, R.
Cats, A.
Hoogerbrugge, N.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[28] GERMLINE CDH1 MUTATIONS FOUND IN A SERIES OF SPORADIC GASTRIC CANCER PATIENTS
Caggiari, L.
De Zorzi, M.
Orzes, E.
Cannizzaro, R.
De Re, V.
DIGESTIVE AND LIVER DISEASE, 2015, 47 : E81 - E81
[29] Novel CDH1 germline mutations identified in Chinese gastric cancer patients
Qin-Hua Chen
Wei Deng
Xiao-Wei Li
Xiu-Fang Liu
Jing-Mei Wang
Li-Feng Wang
Nong Xiao
Qiong He
Ya-Ping Wang
Yi-Mei Fan
World Journal of Gastroenterology, 2013, 19 (06) : 909 - 916
[30] Novel germline CDH1 mutations in hereditary diffuse gastric cancer families
Humar, B
Toro, T
Graziano, F
Müller, H
Dobbie, Z
Kwang-Yang, H
Eng, C
Hampel, H
Gilbert, D
Winship, I
Parry, S
Ward, R
Findlay, M
Christian, A
Tucker, M
Tucker, K
Merriman, T
Guilford, P
HUMAN MUTATION, 2002, 19 (05) : 518 - 525

← 1 2 3 4 5 →